Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5701
Richmond Mutual Bancorp
RMBI
$254M
| $144K | ﹤0.01% |
11,255
+35
| +0.3% | +$460 |
|
5702
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$310M
| $144K | ﹤0.01% |
4,275
+3,892
| +1,016% | +$138K |
|
5703
LiveOne
LVO
$60.4M
| $144K | ﹤0.01% |
20,542
-1,205
| -6% | -$11.9K |
|
5704
Vanguard US Quality Factor ETF
VFQY
$500M
| $143K | ﹤0.01% |
1,070
+663
| +163% | +$93.9K |
|
5705
Richtech Robotics
RR
$382M
| $143K | ﹤0.01% |
72,137
+59,373
| +465% | +$146K |
|
|
FMN
5706
Federated Hermes Premier Municipal Income Fund
FMN
$87.2M
| $143K | ﹤0.01% |
13,148
-215
| -2% | -$2.38K |
|
5707
iShares Asia/Pacific Dividend ETF
DVYA
$72.1M
| $142K | ﹤0.01% |
3,986
+384
| +11% | +$13.9K |
|
5708
T-Rex 2X Long NVIDIA Daily Target ETF
NVDX
$443M
| $142K | ﹤0.01% |
18,255
-8,939
| -33% | -$103K |
|
5709
Innovator US Equity Ultra Buffer ETF January
UJAN
$272M
| $140K | ﹤0.01% |
3,675
| – | – |
|
|
BLUE
5710
DELISTED
bluebird bio
BLUE
| $140K | ﹤0.01% |
28,723
-8,748
| -23% | -$52.6K |
|
5711
JPMorgan Small & Mid Cap Enhanced Equity ETF
JMEE
$2.93B
| $140K | ﹤0.01% |
2,503
| – | – |
|
5712
ProShares UltraShort QQQ
QID
$249M
| $140K | ﹤0.01% |
3,677
-1,146
| -24% | -$38.1K |
|
5713
Southland Holdings
SLND
$33M
| $140K | ﹤0.01% |
46,823
-2,591
| -5% | -$8.42K |
|
5714
Immix Biopharma
IMMX
$721M
| $138K | ﹤0.01% |
82,292
-8,759
| -10% | -$16.5K |
|
5715
Orchestra BioMed
OBIO
$267M
| $138K | ﹤0.01% |
32,134
-19,497
| -38% | -$96.9K |
|
5716
Invesco High Income Trust II
VLT
$65.8M
| $137K | ﹤0.01% |
12,927
-6,430
| -33% | -$70.2K |
|
|
WMPN
5717
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $137K | ﹤0.01% |
12,509
-22,368
| -64% | -$264K |
|
|
RGLS
5718
DELISTED
Regulus Therapeutics
RGLS
| $136K | ﹤0.01% |
77,621
-62,170
| -44% | -$82K |
|
5719
Paysign
PAYS
$707M
| $136K | ﹤0.01% |
64,053
-32,884
| -34% | -$87.8K |
|
5720
SES AI
SES
$196M
| $135K | ﹤0.01% |
259,610
-41,006
| -14% | -$37.7K |
|
5721
Envela
ELA
$417M
| $135K | ﹤0.01% |
21,652
+5,876
| +37% | +$38.2K |
|
5722
X4 Pharmaceuticals
XFOR
$421M
| $135K | ﹤0.01% |
19,000
+650
| +4% | +$8.95K |
|
5723
AC Immune
ACIU
$232M
| $135K | ﹤0.01% |
72,004
-94,551
| -57% | -$238K |
|
|
ORGN
5724
DELISTED
Origin Materials
ORGN
| $135K | ﹤0.01% |
6,763
+146
| +2% | +$4.01K |
|
5725
Waldencast
WALD
$178M
| $134K | ﹤0.01% |
44,769
-52,072
| -54% | -$169K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.